#United States #Charlotte #Tract Bio #The Pearl #Connect Labs

Tract Bio Unveils State-of-the-Art Laboratory in Charlotte

Tract Bio, a groundbreaking biotechnology firm dedicated to the discovery and development of innovative therapies targeting cancer and inflammatory conditions, has made a significant stride by inaugurating its new laboratory at the Pearl Innovation District in Charlotte, North Carolina. The grand opening ceremony, celebrated on November 12, 2025, signals a major step forward for the company in advancing its research and development endeavors.

The new facility is strategically situated within the Connect Labs by Wexford, a cutting-edge laboratory infrastructure designed for emerging companies in the life sciences sector. This location offers Tract Bio enhanced laboratory capabilities essential for pursuing its mission of revolutionizing treatments for cancers and inflammatory diseases. The Pearl serves as a transformative hub for health innovation, fostering connections with other leading scientific institutions and biotech enterprises.

Richard Russell, the CEO of Tract Bio, expressed excitement about this new chapter: "Our new lab marks a significant milestone in Tract's evolution and reflects our progress toward bringing potentially life-changing treatments to patients with cancer and inflammatory diseases. We are thrilled to call The Pearl our research home as it connects us directly to leading scientific and clinical expertise within a vibrant and growing life science community, an ideal setting to accelerate our research programs, expand our team, and advance our mission."

Alongside the opening of the lab, Tract's scientific co-founders, Dr. Frank McKeon and Dr. Wa Xian, have also joined the faculty at the Wake Forest University School of Medicine as professors of Cancer Biology. This collaboration aligns with the school’s Charlotte campus, notable for being the city's first four-year medical institution.

The Pearl Innovation District, which hosts Connect Labs, is dedicated to supporting bold ideas in medical science and innovation. The laboratory facilities are designed to be flexible and scale in place, catering to the evolving needs of biotechnology companies. By providing fully furnished labs, support spaces, and amenities, Connect Labs is tailored to empower companies to focus on advancing their commercial ventures while supporting resource sharing and collaboration among peers.

Craig Scharton, director of Connect Labs Charlotte, stated, "We are thrilled to welcome Tract Bio to Connect Labs. Our facilities were intentionally designed to unlock the next generation of clinical and biomedical breakthroughs by bringing together advanced technology and medical expertise. The addition of Tract Bio exemplifies the pioneering spirit and collaborative energy that define this ecosystem."

Tract Bio is recognized for its proprietary approach, utilizing FAP (Fibroblast Activation Protein) targeted prodrugs and the innovative stem cell discovery platform called stemECHO. These technologies are designed to enhance the efficacy and safety of therapies aimed at a range of cancers, including chronic myeloid leukemia, multiple myeloma, and various solid tumors, as well as a variety of inflammatory diseases.

The company is currently advancing TP-101, an innovative combination therapy identified through the stemECHO platform aimed at targeting disease-associated stem cells in cancer. By leveraging advanced methodologies and a skilled team, Tract Bio remains committed to transforming the treatment landscape for patients with significant unmet medical needs.

As Tract Bio embarks on this new journey at The Pearl, the biotechnology community looks forward to the advancements that this innovative laboratory will facilitate, potentially impacting the lives of countless patients in the fight against cancer and inflammatory diseases.

For more information about Tract Bio and its innovative treatments, please visit their website or follow their press releases for updates on their latest projects and breakthroughs.